/Lists

Biotech Series A Investors & VC Firms

1626 firms in this list, with a median first check of $500K. 369 of them lead rounds. Generated from verified public data and updated continuously.

Y Combinator
San FranciscoPre-Seed–Series A$500K
111 people
Andreessen Horowitz
Menlo ParkSeed–Growth$500K – $50M
626 people
Antler
SingaporePre-Seed–Series C$125K
327 people
Alumni Ventures
ManchesterPre-Seed–Late Stage$100K – $10M
111 people
General Catalyst
San FranciscoPre-Seed–Late Stage$30M
222 people
Sequoia Capital
Menlo ParkPre-Seed–Late Stage$100K – $50M
157 people
Bessemer Venture Partners
San FranciscoSeed–Growth$50K – $100M
255 people
Lightspeed Venture Partners
Menlo ParkSeed–Late Stage$1M – $5M
117 people
New Enterprise Associates (NEA)
Menlo ParkSeed–Growth$200K – $40M
81 people
GV (Google Ventures)
Mountain ViewSeed–Late Stage$250K – $50M
126 people
Norwest Venture Partners
Menlo ParkSeed–Late Stage$10M – $30M
185 people
RA Capital
BostonSeed–Late Stage
282 people
Khosla Ventures
Menlo ParkPre-Seed–Growth$100K – $20M
49 people
Bain Capital
BostonPre-Seed–Late Stage
290 people
Kleiner Perkins
Menlo ParkPre-Seed–Growth$500K – $15M
37 people
SOSV
New YorkPre-Seed–Series B$30K – $550K
91 people
Index Ventures
San FranciscoSeed–Growth$540K – $10.8M
67 people
F-Prime Capital
CambridgePre-Seed–Series C$3M – $10M
110 people
SV Angel
San FranciscoPre-Seed–Growth$150K – $20M
12 people
PMV
BrusselsPre-Seed–Growth
210 people
Felicis Ventures
San FranciscoPre-Seed–Growth$500K – $15M
48 people
Valor Equity Partners
ChicagoSeed–Growth
127 people
Qiming Venture Partners
BeijingSeed–Series B
64 people
Menlo Ventures
San FranciscoPre-Seed–Late Stage$1M – $20M
55 people

Frequently asked questions

Who are the top biotech series a investors & vc firms?
Top biotech series a investors & vc firms include Y Combinator, Andreessen Horowitz, Antler, Alumni Ventures, General Catalyst, Sequoia Capital, Bessemer Venture Partners, Lightspeed Venture Partners — 1626 firms in total meet the criteria.
What is the typical first check among biotech series a investors & vc firms?
The median first check among the 1626 biotech series a investors & vc firms tracked here is $500K.
How many biotech series a investors & vc firms lead rounds?
369 of the 1626 biotech series a investors & vc firms tracked here lead investment rounds.

Related lists

Data sourced from public filings and firms' own websites — see our methodology.